DK0975648T3 - Morfinderivater - Google Patents

Morfinderivater

Info

Publication number
DK0975648T3
DK0975648T3 DK98917345T DK98917345T DK0975648T3 DK 0975648 T3 DK0975648 T3 DK 0975648T3 DK 98917345 T DK98917345 T DK 98917345T DK 98917345 T DK98917345 T DK 98917345T DK 0975648 T3 DK0975648 T3 DK 0975648T3
Authority
DK
Denmark
Prior art keywords
morphine
glucuronide
adducts
formula
acid
Prior art date
Application number
DK98917345T
Other languages
English (en)
Inventor
Feodor Scheinmann
Andrew Valentine Stachulski
Simon Joel
Original Assignee
Ufc Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/833,203 external-priority patent/US5977326A/en
Priority claimed from GBGB9721137.9A external-priority patent/GB9721137D0/en
Application filed by Ufc Ltd filed Critical Ufc Ltd
Application granted granted Critical
Publication of DK0975648T3 publication Critical patent/DK0975648T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK98917345T 1997-04-14 1998-04-14 Morfinderivater DK0975648T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/833,203 US5977326A (en) 1991-08-06 1997-04-14 Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
GBGB9721137.9A GB9721137D0 (en) 1997-10-07 1997-10-07 Morphine derivatives
PCT/GB1998/001071 WO1998046618A1 (en) 1997-04-14 1998-04-14 Morphine derivatives

Publications (1)

Publication Number Publication Date
DK0975648T3 true DK0975648T3 (da) 2003-09-29

Family

ID=26312371

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98917345T DK0975648T3 (da) 1997-04-14 1998-04-14 Morfinderivater

Country Status (9)

Country Link
EP (1) EP0975648B1 (da)
JP (1) JP2001518912A (da)
AT (1) ATE242257T1 (da)
AU (1) AU723859B2 (da)
DE (1) DE69815336T2 (da)
DK (1) DK0975648T3 (da)
ES (1) ES2201482T3 (da)
GB (1) GB2339196B (da)
WO (1) WO1998046618A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
FR2907121B1 (fr) 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939436B1 (fr) 2008-12-10 2010-12-17 Sanofi Aventis Synthese de morphine-6-glucuronide ou de l'un de ses derives
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP3082782A1 (en) 2013-12-17 2016-10-26 Laboratorios Del. Dr. Esteve, S.A. SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325065D0 (en) * 1993-12-07 1994-02-02 Salford Ultrafine Chem & Res An enzymatic process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
EP0816375A1 (en) * 1995-11-29 1998-01-07 Rolabo Sl Glycoconjugates of opiated substances

Also Published As

Publication number Publication date
GB2339196A8 (en) 2000-01-24
AU7059098A (en) 1998-11-11
AU723859B2 (en) 2000-09-07
GB2339196A (en) 2000-01-19
WO1998046618A1 (en) 1998-10-22
DE69815336T2 (de) 2004-05-06
EP0975648B1 (en) 2003-06-04
JP2001518912A (ja) 2001-10-16
ATE242257T1 (de) 2003-06-15
GB2339196B (en) 2001-11-07
ES2201482T3 (es) 2004-03-16
DE69815336D1 (de) 2003-07-10
EP0975648A1 (en) 2000-02-02
GB9924287D0 (en) 1999-12-15

Similar Documents

Publication Publication Date Title
ATE242257T1 (de) Morphin-derivate
MX9707879A (es) Derivados de piperazina sustituidos novedosos que tienen actividad antagonista de receptor de taquinina.
BG106104A (en) Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
PT1071702E (pt) Derivados de acidos gordos de acidos biliares e derivados de acidos biliares
GR3020483T3 (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
PL340551A1 (en) Derivatives of hydroxamic and carboxylic acids exhibiting mmp & tnf inhibitive action
NO20002702L (no) Tienopyrimidiner
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
ATE253061T1 (de) Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide
PT788480E (pt) Cristalizacao de levobupivacaina e seus analogos
ES2184318T3 (es) 6-alquilfenantridinas sustituidas.
NO307447B1 (no) Anvendelse av et pregnanderivat
KR970703761A (ko) 암 전이 억제제(cancerous metastasis inhibitor)
DE69226487T2 (de) Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten
ES2074946A1 (es) Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
BR0015082A (pt) Derivado de ácido hidroxâmico como inibidor da formação de cd 23 humano solúvel
SE0004462D0 (sv) Novel method and use
ZA954947B (en) Novel substituted alkyldiamine derivatives
ID22762A (id) Komposisi untuk mengobati atau mencegah kanker prostat
EA199900174A1 (ru) Способ лечения биполярного расстройства
MY103537A (en) Treatment of cardiac arrhythmias.
DE69826287D1 (de) Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung
MD980248A (ro) Derivaţi ai carbolinei